BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Bacillus coagulans R11 maintained intestinal villus health and decreased intestinal injury in lead-exposed mice by regulating the intestinal microbiota and influenced the function of faecal microRNAs. ✅
Go to Publication ✅
Environmental pollution (Barking, Essex : 1987) (Environ Pollut ) Vol: 255 Issue Pt 2 Pages: 113139 Pub: 2019 Sep 13 Epub: 2019 Sep 13 Authors Xing SC , Huang CB , Mi JD , Wu YB , Liao XD , |
|
|
Treatment with a spore-based probiotic containing five strains of Bacillus induced changes in the metabolic activity and community composition of the gut microbiota in a SHIME® model of the human gastrointestinal system. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 149 Issue Pages: 110676 Pub: 2021 Nov Epub: 2021 Aug 30 Authors Marzorati M , Van den Abbeele P , Bubeck S , Bayne T , Krishnan K , Young A , |
|
|
Treatment with a spore-based probiotic containing five strains of Bacillus induced changes in the metabolic activity and community composition of the gut microbiota in a SHIME® model of the human gastrointestinal system. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 149 Issue Pages: 110676 Pub: 2021 Nov Epub: 2021 Aug 30 Authors Marzorati M , Van den Abbeele P , Bubeck S , Bayne T , Krishnan K , Young A , |
|
|
Bacillus coagulans prevents the decline in average daily feed intake in young piglets infected with enterotoxigenic Escherichia coli K88 by reducing intestinal injury and regulating the gut microbiota. ✅
Go to Publication ✅
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 13 Issue Pages: 1284166 Pub: 2023 Epub: 2023 Nov 14 Authors Zhang Y , Tian X , Dong Y , Li R , Shen M , Yi D , Wu T , Wang L , Zhao D , Hou Y , |
|
|
Bacillus coagulans prevents the decline in average daily feed intake in young piglets infected with enterotoxigenic Escherichia coli K88 by reducing intestinal injury and regulating the gut microbiota. ✅
Go to Publication ✅
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 13 Issue Pages: 1284166 Pub: 2023 Epub: 2023 Nov 14 Authors Zhang Y , Tian X , Dong Y , Li R , Shen M , Yi D , Wu T , Wang L , Zhao D , Hou Y , |
|
|
Probiotic modulation of gut microbiota by Bacillus coagulans MTCC 5856 in healthy subjects: A randomized, double-blind, placebo-control study. ✅
Go to Publication ✅
Medicine (Medicine (Baltimore) ) Vol: 102 Issue 20 Pages: e33751 Pub: 2023 May 19 Epub: Authors Majeed M , Nagabhushanam K , Mundkur L , Paulose S , Divakar H , Rao S , Arumugam S , |
|
|
Bacillus coagulans SANK 70258 suppresses Enterobacteriaceae in the microbiota of ulcerative colitis in vitro and enhances butyrogenesis in healthy microbiota. ✅
Go to Publication ✅
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 104 Issue 9 Pages: 3859-3867 Pub: 2020 May Epub: 2020 Mar 7 Authors Sasaki K , Sasaki D , Inoue J , Hoshi N , Maeda T , Yamada R , Kondo A , |
|
|
Weizmannia coagulans BC99 Enhances Intestinal Barrier Function by Modulating Butyrate Formation to Alleviate Acute Alcohol Intoxication in Rats. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 23 Pages: Pub: 2024 Nov 29 Epub: 2024 Nov 29 Authors Li C , Zhai S , Duan M , Cao L , Zhang J , Wang Y , Wu Y , Gu S , |
|
|
Effect of Probiotic Product Containing Heyndrickxia coagulans TBC169 on Hyperuricemia in Rats. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2025 Mar 24 Epub: 2025 Mar 24 Authors Duan L , Zhang X , Wang D , Xin J , Jiang Y , Sun N , Chen B , Luo J , He Y , Pan K , Zeng Y , Jing B , Ni X , Liu H , |
|
|
Effect of Probiotic Product Containing Heyndrickxia coagulans TBC169 on Hyperuricemia in Rats. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2025 Mar 24 Epub: 2025 Mar 24 Authors Duan L , Zhang X , Wang D , Xin J , Jiang Y , Sun N , Chen B , Luo J , He Y , Pan K , Zeng Y , Jing B , Ni X , Liu H , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
